12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 01/21 12:07
Gainers
- Helius Medical Tech (NASDAQ:HSDT) stock rose 47.8% to $1.11 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
- Dogwood Therapeutics (NASDAQ:DWTX) shares increased by 36.89% to $2.56. The market value of their outstanding shares is at $3.4 million.
- TNF Pharmaceuticals (NASDAQ:TNFA) shares rose 19.82% to $1.39. The market value of their outstanding shares is at $3.8 million.
- Redhill Biopharma (NASDAQ:RDHL) stock increased by 19.75% to $6.75. The company's market cap stands at $8.6 million.
- Tempus AI (NASDAQ:TEM) shares rose 19.14% to $41.88. The company's market cap stands at $6.5 billion.
- Design Therapeutics (NASDAQ:DSGN) stock rose 17.39% to $5.94. The company's market cap stands at $336.3 million.
Losers
- Baird Medical Investment (NASDAQ:BDMD) shares declined by 14.1% to $7.6 during Tuesday's pre-market session. The market value of their outstanding shares is at $276.3 million.
- AEON Biopharma (AMEX:AEON) shares fell 12.47% to $0.13. The market value of their outstanding shares is at $10.7 million.
- Biomerica (NASDAQ:BMRA) stock decreased by 10.94% to $0.57. The company's market cap stands at $10.4 million.
- Akoya Biosciences (NASDAQ:AKYA) stock fell 10.64% to $2.52. The market value of their outstanding shares is at $124.9 million.
- Rapid Micro Biosystems (NASDAQ:RPID) shares fell 9.76% to $1.11. The company's market cap stands at $47.7 million.
- Bio-Rad Laboratories (NYSE:BIO) stock decreased by 9.1% to $310.0. The company's market cap stands at $8.8 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.